SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-076822
Filing Date
2014-11-05
Accepted
2014-11-05 09:09:07
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19672_110q.htm 10-Q 896644
2 EX-10.1 a14-19672_1ex10d1.htm EX-10.1 360065
3 EX-31.1 a14-19672_1ex31d1.htm EX-31.1 12590
4 EX-31.2 a14-19672_1ex31d2.htm EX-31.2 12592
5 EX-32.1 a14-19672_1ex32d1.htm EX-32.1 7801
  Complete submission text file 0001104659-14-076822.txt   5174652

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cldx-20140930.xml EX-101.INS 731659
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20140930.xsd EX-101.SCH 30745
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20140930_cal.xml EX-101.CAL 61000
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20140930_lab.xml EX-101.LAB 312046
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20140930_pre.xml EX-101.PRE 200111
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20140930_def.xml EX-101.DEF 88631
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 141195354
SIC: 2835 In Vitro & In Vivo Diagnostic Substances